According to a report by Winnipeg Sun, a Canadian news agency, Manitoba province is planning to increase taxation on e-cigarette products next year as a measure to deter their usage, particularly among the youth.
The government of Manitoba is planning to double the current federal sales tax in the spring budget, with the aim of implementing the tax increase around July 1.
Manitoba Premier Wab Kinew states:
The e-cigarette tax is a way for us to convey the dangers of smoking, particularly to young people, but also to all Manitobans. This is yet another step in Manitoba's alignment with other provinces.
He disclosed that it is expected that the consumption tax will generate 11 million Canadian dollars (approximately 6 million RMB) in revenue for local governments throughout the year, and this money will aid in funding anti-smoking and anti-e-cigarette projects.
The Canadian federal government implemented new taxes in the autumn of 2022, and some provinces have also introduced their own taxes. Saskatchewan announced in 2021 that it would impose a 20% provincial tax. Last month, Ontario announced that it would double the federal sales tax, and Manitoba is also planning to do the same.
After the merger, manufacturers and importers will be required to pay 2 Canadian dollars for every 10 milliliters of aerosol, after the first 10 milliliters, which will cost 2 Canadian dollars for every 2 milliliters.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
